Showing results (51-60 of 78) with videos related to

Sort By:
Pageof 8
The Journal of Clinical Investigation|May 9, 2012
Protein disulfide isomerase inhibitors constitute a new class of antithrombotic agentsReema Jasuja, Freda H Passam, Daniel R Kennedy, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|November 11, 2025
Evaluation of toxicity after radical hysterectomy or trachelectomy and post-operative pelvic intensity-modulated radiation therapy with concurrent chemotherapy for cervical cancerBeryl L Manning-Geist, Madison Miller, Christian Dagher, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 3, 2026
Assessing the clinical value of pre-operative imaging in endometrial carcinoma by symptoms and low-risk versus high-risk histologyClarissa Lam, Christian Dagher, Vance Broach, et al.
Gynecologic Oncology|October 18, 2025
Prognostic value of positive peritoneal cytology in FIGO 2009 stage IA grade 1 endometrioid endometrial cancerChristian Dagher, Pier Selenica, Carsten F J Bakhuis, et al.
Cancers|March 11, 2023
Phase I Study of a Multivalent WT1 Peptide Vaccine (Galinpepimut-S) in Combination with Nivolumab in Patients with WT1-Expressing Ovarian Cancer in Second or Third RemissionBeryl L Manning-Geist, Sacha Gnjatic, Carol Aghajanian, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 7, 2025
Effect of substantial lymphovascular space invasion on location of first disease recurrence in surgical stage I endometrioid endometrial adenocarcinomaChristian Dagher, Pernille Bjerre Trent, Rofieda Alwaqfi, et al.
International Journal of Cancer|May 9, 2020
Oncogenic properties and signaling basis of the PAX8-GLIS3 fusion geneThais Basili, Higinio Dopeso, Sarah H Kim, et al.
Elife|February 3, 2026
Repression of PRMT activities sensitize human homologous recombination-proficient ovarian and breast cancer cells to PARP inhibitor treatmentYouyou Zhang, Mu Xu, Jiao Yuan, et al.
JCO Precision Oncology|October 14, 2022
Risk Stratification of Stage I Grade 3 Endometrioid Endometrial Carcinoma in the Era of Molecular ClassificationWilliam A Zammarrelli, Sarah H Kim, Arnaud Da Cruz Paula, et al.
Gynecologic Oncology|June 30, 2023
Patient-reported symptoms after minimally invasive hysterectomy and association with postoperative complicationsJacqueline Feinberg, Oliver Zivanovic, Michael Hannon, et al.
Pageof 8